Focue Provides the Latest and Most Up-to-Date News, What You Focus On is What You Get.
⎯ 《 Focue • Com 》

List of All Articles with Tag 'amgen'

U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
1970-01-01 08:00
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
By Deena Beasley The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics
1970-01-01 08:00
Amgen settles with the FTC over $28 billion deal
Amgen settles with the FTC over $28 billion deal
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September.
1970-01-01 08:00
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
By Manas Mishra and David Shepardson (Reuters) -The U.S. Federal Trade Commission has allowed Amgen to go ahead with its
1970-01-01 08:00
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics,
1970-01-01 08:00
California, other states join FTC bid to block Amgen deal
California, other states join FTC bid to block Amgen deal
The states of California, Minnesota and Wisconsin on Thursday joined a Federal Trade Commission lawsuit to stop Amgen's
1970-01-01 08:00
FTC effort to stop Amgen's Horizon takeover faces uphill fight
FTC effort to stop Amgen's Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen
1970-01-01 08:00
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive
1970-01-01 08:00
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a
1970-01-01 08:00
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon
1970-01-01 08:00
FTC to block Amgen's deal to acquire Horizon Therapeutics - source
FTC to block Amgen's deal to acquire Horizon Therapeutics - source
The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block
1970-01-01 08:00